Drug Shortage Report for MAXIDEX
| Report ID | 170485 |
| Drug Identification Number | 00042560 |
| Brand name | MAXIDEX |
| Common or Proper name | MAXIDEX 0.1% SUSPENSION |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE |
| Strength(s) | 0.1% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-10-26 |
| Actual start date | |
| Estimated end date | 2022-11-21 |
| Actual end date | 2022-11-17 |
| Shortage status | Resolved |
| Updated date | 2024-01-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v19 | 2024-01-30 | English | Compare |
| v18 | 2022-11-22 | French | Compare |
| v17 | 2022-11-22 | English | Compare |
| v16 | 2022-11-16 | French | Compare |
| v15 | 2022-11-16 | English | Compare |
| v14 | 2022-11-15 | French | Compare |
| v13 | 2022-11-15 | English | Compare |
| v12 | 2022-10-27 | English | Compare |
| v11 | 2022-10-24 | French | Compare |
| v10 | 2022-10-24 | English | Compare |
| v9 | 2022-10-21 | English | Compare |
| v8 | 2022-10-21 | French | Compare |
| v7 | 2022-10-21 | English | Compare |
| v6 | 2022-10-21 | English | Compare |
| v5 | 2022-10-18 | French | Compare |
| v4 | 2022-10-18 | English | Compare |
| v3 | 2022-10-18 | English | Compare |
| v2 | 2022-09-29 | French | Compare |
| v1 | 2022-09-29 | English | Compare |
Showing 1 to 19 of 19